Image of hexagons overlapping in different sizes

Workshop Session 3 - Hot Topic – FDA MAPP 5019.1 Allowable Excess Volume Content in Injectable Drug and Biological Products - a.k.a. deliverable volume gross content 2025

Home / Papers and Presentations / Resource

Papers and Presentations
- CASSS On Demand

Image of purple background with text 'WCBP'

Speaker Presentation: WCBP 2025
Workshop Session 3 - Hot Topic – FDA MAPP 5019.1 Allowable Excess Volume Content in Injectable Drug and Biological Products - a.k.a. deliverable volume gross content 2025